Neuroendocrine tumor (NET) research supported by nonprofit foundation The Neuroendocrine Tumor Research Foundation (NETRF) continues its aggressive funding of neuroendocrine cancer research with eight new grants totaling $2.5 million. With this newest round of funding, NETRF expands its portfolio to include research into lung neuroendocrine tumors (NETs), which affect about one in four NET patients. […]Continue Reading ...
Pheochromocytomas and paragangliomas are uncommon neuroendocrine tumours with a powerful hereditary element.Continue Reading ...
April 27, 2017 The Neuroendocrine Tumor Analysis Basis (NETRF) nowadays introduced its greatest examine dedication ever — $Four million in collaborative grants — maximum from its new Accelerator Grants program to check neuroendocrine tumors (NETs), a extensively misunderstood, regularly misdiagnosed most cancers kind, with out adequately known genomic drivers. Accelerator Grants acknowledge leading edge and […]Continue Reading ...
- Smart assistants could help combat opioid crisis
- Diagnostic stewardship strategy reduces inappropriate testing
- Three-antibiotic cocktail eradicates ‘persister’ Lyme bacteria in mouse model
- Study investigates how early blindness shapes sound processing
- Outcomes Worse for Cancer Patients Seen at Noncancer EDs
- Link found between temperament of high-risk infants and obesity
- Al Letson explores ties between journalists and doctors at Medicine and the Muse symposium
- New mobile phone game can detect people at risk of Alzheimer’s
- Exercise activates brain circuits associated with memory in older adults
- Veggies, Fruits and Grains Keep Your Heart Pumping
- Healthy meal kits can boost children’s long-term health
- Designing an inexpensive surgical headlight: A Q&A with a Stanford surgeon
- States Weigh Banning A Widely Used Pesticide Even Though EPA Won’t
- Integrator complex proteins are crucial for healthy brain development in fruit flies, study finds
- Device converts brain signals into speech, offering hope for patients
- Measles vaccination rates are a ‘public health time bomb’
- Maths made easier for scientists students who shun the subject wins award
- Researchers decode how cancer drug works in brains of Parkinson’s disease patients
- Smarter Brain Cancer Trial Comes to Columbia
- Researchers Seek Sage Advice Of Elders On Aging Issues